Gil Ho Lee

Dr. Gil Ho Lee

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CNChoong-kyun Noh
Choong-kyun Noh
ELEunyoung Lee
Eunyoung Lee
GLGil Ho Lee
Gil Ho Lee
SLSun Gyo Lim
Sun Gyo Lim
BPBumhee Park
Bumhee Park
KLKee Myung Lee
Kee Myung Lee
Although regular endoscopic screening may help in early detection of gastric cancer, interval cancer remains a problem in the screening program. This study evaluated the association between regular endoscopic screening and interval cancer detection in the Korean National Cancer Screening Program (KNCSP). We defined three groups (regularly, irregularly, and not screened) according to the screening interval, and the trends in the interval cancer rate (ICR) between the groups were tested using the Cochran–Armitage test. The influence of regular endoscopic screening on the risk of interval cancer was evaluated using multivariable logistic regression. Among the 11,642,410 participants who underwent endoscopy, the overall ICR was 0.36 per 1000 negative screenings. The ICR of the not screened group (0.41) was the highest among the three groups and the risk of interval cancer in this group was 1.68 times higher (p < 0.001) than that in the regularly screened group. Women in their 40s who had regular screening with no history of intestinal metaplasia and gastric polyps would have the lowest probability of having interval cancer (0.005%). Regular participation in endoscopic screening programs for reducing the risk of interval cancer may help to improve the quality of screening programs.

14 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CNChoong-kyun Noh
Choong-kyun Noh
ELEunyoung Lee
Eunyoung Lee
BPBumhee Park
Bumhee Park
SLSun Gyo Lim
Sun Gyo Lim
SSSung Jae Shin
Sung Jae Shin
GLGil Ho Lee
Gil Ho Lee
The long-term effect of Helicobacter pylori eradication on metachronous gastric neoplasm prevention after endoscopic submucosal dissection (ESD) of gastric adenoma is unclear. This study included patients with confirmed H. pylori infection after ESD with curative resection for gastric adenoma. Patients were divided based on the success of H. pylori eradication treatment into two groups: eradication and non-eradication. Patients with any newly detected lesion within 1 year after ESD and recurrence at the ESD site were excluded from the analysis. Further, 1:1 propensity score matching was also performed to eliminate baseline differences between the two groups. H. pylori eradication treatment was administered to 673 patients after ESD (163 in the successful eradication group and 510 in the non-eradication group). During the median follow-up periods of 25 and 39 months in the eradication and non-eradication groups, metachronous gastric neoplasm was identified in 6 (3.7%) and 22 patients (4.3%), respectively. Adjusted Cox analysis revealed that H. pylori eradication was not associated with increased risk of metachronous gastric neoplasm after ESD. Kaplan–Meier analysis in the matched population yielded similar findings (p = 0.546). H. pylori eradication treatment was not associated with metachronous gastric neoplasm after ESD with curative resection for gastric adenoma.

3 June 2019 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
GLGil Ho Lee
Gil Ho Lee
MYMin Jae Yang
Min Jae Yang
JKJin Kim
Jin Kim
JHJae Chul Hwang
Jae Chul Hwang
BYByung Moo Yoo
Byung Moo Yoo
DLDon-Haeng Lee
Don-Haeng Lee

30 November 2025 in Clinical Endoscopy
Verified
Journal Article
Open access
JPJong Sun Park
Jong Sun Park
HJHye Lynn Jeon
Hye Lynn Jeon
BPBumhee Park
Bumhee Park
JPJong Hoon Park
Jong Hoon Park
GLGil Ho Lee
Gil Ho Lee
CNChoong-kyun Noh
Choong-kyun Noh
Background/Aims: Surveillance strategies for small grade 1 rectal neuroendocrine tumors (G1 rNETs) after incomplete endoscopic resection (ER) remain controversial. We evaluated the long-term outcomes of patients with G1 rNET ≤1 cm after ER who did and did not undergo complete resection.Methods: We retrospectively evaluated 441 patients with G1 rNETs measuring ≤1 cm after ER between 2011 and 2022. Patients were divided into complete and incomplete resection groups according to histopathological evaluation. Logistic regression analysis identified the risk factors for incomplete resection after ER.Results: The mean follow-up intervals were 38.6 and 45.7 months in all patients and the incomplete resection group, respectively. No recurrences were observed during the follow-up period. The mean lesion size was 5.5 mm and the complete resection rate was 80.5% (n=355). In the logistic regression analysis, lesion size 5.1 to 10 mm (odds ratio [OR], 2.3; 95% confidence interval [CI], 1.245–4.203; p=0.008), multiple lesions (OR, 8.3; 95% CI, 1.247–54.774; p=0.029), and retroflexion view during the procedure (OR, 4.0; 95% CI, 1.668–9.615; p=0.002) were independent risk factors for incomplete resection.Conclusions: The prognosis of G1 rNET ≤1 cm after ER was very good, regardless of the histopathological results.

8 October 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YLYu Ji Li
Yu Ji Li
GLGil Ho Lee
Gil Ho Lee
MYMin Jae Yang
Min Jae Yang
JHJae Chul Hwang
Jae Chul Hwang
BYByung Moo Yoo
Byung Moo Yoo
JKJin Kim
Jin Kim
Detection rates of pancreatic cystic lesions (PCLs) have increased, resulting in greater requirements for regular monitoring using imaging modalities. We aimed to evaluate the capability of ultrasonography (US) for morphological characterization of PCLs as a reference standard using endoscopic ultrasonography (EUS). A retrospective analysis was conducted of 102 PCLs from 92 patients who underwent US immediately prior to EUS between January 2014 and May 2017. The intermodality reliability and agreement of the PCL morphologic findings of the two techniques were analyzed and compared using the intraclass correlation coefficient and κ values. The success rates of US for delineating PCLs in the head, body, and tail of the pancreas were 77.8%, 91.8%, and 70.6%, respectively. The intraclass correlation coefficient for US and the corresponding EUS lesion size showed very good reliability (0.978; p < 0.001). The κ value between modalities was 0.882 for pancreatic duct dilation, indicating good agreement. The κ values for solid components and cystic wall and septal thickening were 0.481 and 0.395, respectively, indicating moderate agreement. US may be useful for monitoring PCL growth and changes in pancreatic duct dilation, but it has limited use in the diagnosis and surveillance of mural nodules or cystic wall thickness changes.

15 July 2020 in Gut and Liver
Verified
Journal Article
Open access
PDF file
CNChoong-kyun Noh
Choong-kyun Noh
IKIn Sung Kim
In Sung Kim
GLGil Ho Lee
Gil Ho Lee
JPJin Woong Park
Jin Woong Park
ELEunyoung Lee
Eunyoung Lee
KLKee Myung Lee
Kee Myung Lee
Choong-Kyun Noh, In Sung Kim, Gil Ho Lee, Jin Woong Park, Eunyoung Lee, Bumhee Park, Hye Jeon Hong, Sun Gyo Lim, Sung Jae Shin, Jin Hong Kim, and Kee Myung Lee. Gut and Liver 2020;14:468-76. https://doi.org/10.5009/gnl19199